LBA02-05 NAXIVA - A PHASE II NEOADJUVANT STUDY OF AXITINIB FOR REDUCING EXTENT OF VENOUS TUMOR THROMBUS IN CLEAR CELL RENAL CELL CANCER WITH VENOUS INVASION: TRANSLATIONAL RESULTS

INTRODUCTION AND OBJECTIVE:Venous tumor thrombus (VTT) extension occurs in 4-15% cases of renal cell cancer (RCC). Although surgery is performed with curative intent, mortality is high (5-15%). The...